Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature

Abstract Background SARS-CoV2 virus could be potentially myopathic. Serum creatinine phosphokinase (CPK) is frequently found elevated in severe SARS-CoV2 infection, which indicates skeletal muscle damage precipitating limb weakness or even ventilatory failure. Case presentation We addressed such a p...

Full description

Bibliographic Details
Main Authors: Badrul Islam, Mohiuddin Ahmed, Zhahirul Islam, S. M. Begum
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Skeletal Muscle
Subjects:
Online Access:https://doi.org/10.1186/s13395-021-00266-5
_version_ 1818961407014600704
author Badrul Islam
Mohiuddin Ahmed
Zhahirul Islam
S. M. Begum
author_facet Badrul Islam
Mohiuddin Ahmed
Zhahirul Islam
S. M. Begum
author_sort Badrul Islam
collection DOAJ
description Abstract Background SARS-CoV2 virus could be potentially myopathic. Serum creatinine phosphokinase (CPK) is frequently found elevated in severe SARS-CoV2 infection, which indicates skeletal muscle damage precipitating limb weakness or even ventilatory failure. Case presentation We addressed such a patient in his forties presented with features of severe SARS-CoV2 pneumonia and high serum CPK. He developed severe sepsis and acute respiratory distress syndrome (ARDS) and received intravenous high dose corticosteroid and tocilizumab to counter SARS-CoV2 associated cytokine surge. After 10 days of mechanical ventilation (MV), weaning was unsuccessful albeit apparently clear lung fields, having additionally severe and symmetric limb muscle weakness. Ancillary investigations in addition with serum CPK, including electromyogram, muscle biopsy, and muscle magnetic resonance imaging (MRI) suggested acute myopathy possibly due to skeletal myositis. Conclusion We wish to stress that myopathogenic medication in SARS-CoV2 pneumonia should be used with caution. Additionally, serum CPK could be a potential marker to predict respiratory failure in SARS-CoV2 pneumonia as skeletal myopathy affecting chest muscles may contribute ventilatory failure on top of oxygenation failure due to SARS-CoV2 pneumonia.
first_indexed 2024-12-20T12:12:56Z
format Article
id doaj.art-e06e0798ea8d46d8ab511bd6ed1960e7
institution Directory Open Access Journal
issn 2044-5040
language English
last_indexed 2024-12-20T12:12:56Z
publishDate 2021-04-01
publisher BMC
record_format Article
series Skeletal Muscle
spelling doaj.art-e06e0798ea8d46d8ab511bd6ed1960e72022-12-21T19:41:13ZengBMCSkeletal Muscle2044-50402021-04-011111710.1186/s13395-021-00266-5Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literatureBadrul Islam0Mohiuddin Ahmed1Zhahirul Islam2S. M. Begum3Laboratory Sciences and Services Division (LSSD), International Center for Diarrhoeal Disease Research, Bangladesh (icddr,b)Bangladesh Specialized HospitalLaboratory Sciences and Services Division (LSSD), International Center for Diarrhoeal Disease Research, Bangladesh (icddr,b)Bangladesh Specialized HospitalAbstract Background SARS-CoV2 virus could be potentially myopathic. Serum creatinine phosphokinase (CPK) is frequently found elevated in severe SARS-CoV2 infection, which indicates skeletal muscle damage precipitating limb weakness or even ventilatory failure. Case presentation We addressed such a patient in his forties presented with features of severe SARS-CoV2 pneumonia and high serum CPK. He developed severe sepsis and acute respiratory distress syndrome (ARDS) and received intravenous high dose corticosteroid and tocilizumab to counter SARS-CoV2 associated cytokine surge. After 10 days of mechanical ventilation (MV), weaning was unsuccessful albeit apparently clear lung fields, having additionally severe and symmetric limb muscle weakness. Ancillary investigations in addition with serum CPK, including electromyogram, muscle biopsy, and muscle magnetic resonance imaging (MRI) suggested acute myopathy possibly due to skeletal myositis. Conclusion We wish to stress that myopathogenic medication in SARS-CoV2 pneumonia should be used with caution. Additionally, serum CPK could be a potential marker to predict respiratory failure in SARS-CoV2 pneumonia as skeletal myopathy affecting chest muscles may contribute ventilatory failure on top of oxygenation failure due to SARS-CoV2 pneumonia.https://doi.org/10.1186/s13395-021-00266-5MyopathyGuillain-Barré syndromeNerve conductionElectromyogramSARS-CoV2
spellingShingle Badrul Islam
Mohiuddin Ahmed
Zhahirul Islam
S. M. Begum
Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature
Skeletal Muscle
Myopathy
Guillain-Barré syndrome
Nerve conduction
Electromyogram
SARS-CoV2
title Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature
title_full Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature
title_fullStr Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature
title_full_unstemmed Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature
title_short Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature
title_sort severe acute myopathy following sars cov 2 infection a case report and review of recent literature
topic Myopathy
Guillain-Barré syndrome
Nerve conduction
Electromyogram
SARS-CoV2
url https://doi.org/10.1186/s13395-021-00266-5
work_keys_str_mv AT badrulislam severeacutemyopathyfollowingsarscov2infectionacasereportandreviewofrecentliterature
AT mohiuddinahmed severeacutemyopathyfollowingsarscov2infectionacasereportandreviewofrecentliterature
AT zhahirulislam severeacutemyopathyfollowingsarscov2infectionacasereportandreviewofrecentliterature
AT smbegum severeacutemyopathyfollowingsarscov2infectionacasereportandreviewofrecentliterature